Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Allogeneic HSCT; Posttransplant Complications; GvHD; Relapse; Acute Myeloid Leukemia Interventions: Diagnostic Test: blood draw Sponsors: University Hospital Pilsen Not yet recruiting Conditions: Allogeneic HSCT; Posttransplant Complications; GvHD;...

BIS-Guided Sedation Versus Standard Clinical Sedation During Elective Electrical Cardioversion for Atrial Fibrillation

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Atrial Fibrillation; Electric Countershock; Deep Sedation Interventions: Drug: BIS-guided propofol sedation; Drug: Clinical-guided propofol sedation Sponsors: Istanbul University – Cerrahpasa Not yet recruiting Conditions: Atrial Fibrillation;...

Improved Child Nutrition and Development Through Social Transfers

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Breastfeeding; Breastfeeding Education; Breastfeeding Duration; Breastfeeding Continuation; Child Growth; Stress; Infectious Diseases; Anemia; Child Development; Weight Loss; Blood Pressure; Mental Health; Diarrhea; Coughing; Eczema; Allergies;...

Mucosal and Nasal Involvement and Their Correlation With Smell and Taste Functions in Lichen Planus Patients

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Lichen Planus Interventions: Other: Grup 1 – Lichen Planus Patients Intervention Name: Taste and Smell Testing, Oral and Nasal Examination, Nasal Endoscopy Intervention Description: Participants undergo taste and smell testing to assess Sponsors:...

Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU Admissions

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Intensive Care (ICU); Age Over 80 Years; Hospital Length of Stay; Mortality Interventions: Other: Time in hospital before ICU admission. Sponsors: Uppsala University; Region Dalarna Completed Conditions: Intensive Care (ICU); Age Over 80 Years; Hospital...

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

by palligoelme@gmail.com | May 6, 2026 | Clinical Trials

​ Conditions: Healthy Volunteers; Diabetes Mellitus, Type 2 Interventions: Drug: NNC1679-0001; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting Conditions: Healthy Volunteers; Diabetes Mellitus, Type 2 Interventions: Drug: NNC1679-0001; Drug: Placebo...